Responsabilities
The below described tasks are to be performed. The objective is to develop an ambitious biotechnology analysis framework and integrate relevant data in the management of our assets :
1.ESG Analysis : Evaluate the ESG performance of Health Care companies with a focus on small biotechnology companies, leveraging Candriam’s internal ESG evaluation framework
2.Engagement : Organize meetings with issuers in portfolio to drive transparency and change on a range of ESG issues.
3.Assist in the development of an Impact measurement framework for Biotech and Healthcare companies Devise a tool / analysis framework to assess how drug candidates and commercialized drugs benefit patients in developed and in LMIC countries.
Profile